Literature DB >> 33151377

Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case-control studies using a national sample cohort.

J W Lee1, C Min2,3, C H Bang4, B C Kwon5, H G Choi6,7.   

Abstract

A total of 25,306 psoriasis participants were matched to 101,224 controls, and the occurrence of osteoporosis was analyzed. Additionally, 79,212 osteoporosis patients were matched to 79,212 controls and a previous history of psoriasis was analyzed. Psoriasis increased the risk of osteoporosis among participants aged ≥ 40 years.
INTRODUCTION: The aim of the present study was to evaluate the association between psoriasis and osteoporosis using two different studies.
METHODS: Data from the Korean National Health Insurance Service-Health Screening Cohort of participants aged ≥ 40 years were collected from 2002 to 2013. Psoriasis and osteoporosis were included using International Classification of Diseases (ICD)-10 codes. In study I (a follow-up study), a total of 25,306 psoriasis participants were matched to 101,224 controls with respect to age, sex, income, and region of residence, and the occurrence of osteoporosis was analyzed. Crude (simple) and adjusted hazard ratios (HRs) were analyzed using a stratified Cox proportional hazard model. In study II (a nested case-control study), a total of 79,212 osteoporosis patients were matched to 79,212 controls and a previous history of psoriasis was analyzed. Crude and adjusted odds ratios (ORs) were analyzed using a conditional logistic regression analysis. Subgroup analyses were conducted according to age group and sex.
RESULTS: The adjusted HR of osteoporosis was 1.09 (95% confidence interval [CI] = 1.05-1.13, P < 0.001) in study I. In the subgroup analysis according to age and sex, the results were consistent except for ≥ 60-year-old women. The adjusted OR of psoriasis was 1.21 (95% CI = 1.16-1.27, P < 0.001) in study II. All subgroups demonstrated high adjusted ORs of osteoporosis for psoriasis.
CONCLUSIONS: Psoriasis increased the risk of osteoporosis among participants aged ≥ 40 years in Korea.

Entities:  

Keywords:  Case–control studies; Cohort studies; Osteoporosis; Psoriasis; Risk factors

Mesh:

Year:  2020        PMID: 33151377     DOI: 10.1007/s00198-020-05724-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  2 in total

1.  Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation.

Authors:  Johannes Grisar; Peter M Bernecker; Martin Aringer; Kurt Redlich; Markus Sedlak; Wolfgang Wolozcszuk; Susanne Spitzauer; Stephan Grampp; Franz Kainberger; Wolfgang Ebner; Josef S Smolen; Peter Pietschmann
Journal:  J Rheumatol       Date:  2002-07       Impact factor: 4.666

2.  Risk factors for osteoporosis and bone status in postmenopausal women with psoriasis treated with UVB therapy.

Authors:  Amra Osmancevic; Kerstin Landin-Wilhelmsen; Olle Larkö; Dan Mellström; Ann-Marie Wennberg; Lena Hulthén; Anne-Lene Krogstad
Journal:  Acta Derm Venereol       Date:  2008       Impact factor: 4.437

  2 in total
  3 in total

Review 1.  Impact of Chronic Inflammation in Psoriasis on Bone Metabolism.

Authors:  Anja Saalbach; Manfred Kunz
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

Review 2.  Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.

Authors:  Jin Bu; Ruilian Ding; Liangjia Zhou; Xiangming Chen; Erxia Shen
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 3.  Psoriasis and osteoporosis: a literature review.

Authors:  Dohyen Wi; Anna Wilson; Fanny Satgé; Dédée F Murrell
Journal:  Clin Exp Dermatol       Date:  2022-05-25       Impact factor: 4.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.